Bi-allelic loss of function variants of


Journal

Journal of medical genetics
ISSN: 1468-6244
Titre abrégé: J Med Genet
Pays: England
ID NLM: 2985087R

Informations de publication

Date de publication:
09 2019
Historique:
received: 04 12 2018
revised: 22 03 2019
accepted: 24 03 2019
pubmed: 25 4 2019
medline: 12 6 2020
entrez: 25 4 2019
Statut: ppublish

Résumé

Congenital scoliosis (CS) is a common vertebral malformation. Spondylocostal dysostosis (SCD) is a rare skeletal dysplasia characterised by multiple vertebral malformations and rib anomalies. In a previous study, a compound heterozygosity for a null mutation and a risk haplotype composed by three single-nucleotide polymorphisms in We recruited 200 patients with CS or SCD and investigated We identified five 16p11.2 deletions, one splice-site variant and five missense variants in 10 patients. In vitro functional assays for missense variants identified in the previous and present studies demonstrated that most of the variants caused abnormal localisation of TBX6 proteins. We confirmed mislocalisation of TBX6 proteins in presomitic mesoderm cells induced from SCD patient-derived iPS cells. In induced cells, we found decreased mRNA expressions of Our study suggests that bi-allelic loss of function variants of

Sections du résumé

BACKGROUND
Congenital scoliosis (CS) is a common vertebral malformation. Spondylocostal dysostosis (SCD) is a rare skeletal dysplasia characterised by multiple vertebral malformations and rib anomalies. In a previous study, a compound heterozygosity for a null mutation and a risk haplotype composed by three single-nucleotide polymorphisms in
METHODS
We recruited 200 patients with CS or SCD and investigated
RESULTS
We identified five 16p11.2 deletions, one splice-site variant and five missense variants in 10 patients. In vitro functional assays for missense variants identified in the previous and present studies demonstrated that most of the variants caused abnormal localisation of TBX6 proteins. We confirmed mislocalisation of TBX6 proteins in presomitic mesoderm cells induced from SCD patient-derived iPS cells. In induced cells, we found decreased mRNA expressions of
CONCLUSIONS
Our study suggests that bi-allelic loss of function variants of

Identifiants

pubmed: 31015262
pii: jmedgenet-2018-105920
doi: 10.1136/jmedgenet-2018-105920
doi:

Substances chimiques

T-Box Domain Proteins 0
TBX6 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

622-628

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Nao Otomo (N)

Laboratory of Bone and Joint Diseases, RIKEN Center for Integrative Medical Sciences, Tokyo, Japan.
Department of Orthopedic Surgery, Keio University School of Medicine, Tokyo, Japan.

Kazuki Takeda (K)

Laboratory of Bone and Joint Diseases, RIKEN Center for Integrative Medical Sciences, Tokyo, Japan.
Department of Orthopedic Surgery, Keio University School of Medicine, Tokyo, Japan.

Shunsuke Kawai (S)

Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
Department of Regeneration Science and Engineering, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.
Department of Orthopedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Ikuyo Kou (I)

Laboratory of Bone and Joint Diseases, RIKEN Center for Integrative Medical Sciences, Tokyo, Japan.

Long Guo (L)

Laboratory of Bone and Joint Diseases, RIKEN Center for Integrative Medical Sciences, Tokyo, Japan.

Mitsujiro Osawa (M)

Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.

Cantas Alev (C)

Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.

Noriaki Kawakami (N)

Department of Orthopaedic Surgery, Meijo Hospital, Nagoya, Japan.

Noriko Miyake (N)

Department of Human Genetics, Yokohama City University Graduated School of Medicine, Yokohama, Japan.

Naomichi Matsumoto (N)

Department of Human Genetics, Yokohama City University Graduated School of Medicine, Yokohama, Japan.

Yukuto Yasuhiko (Y)

Division of Cellular and Molecular Toxicology, National Institute of Health Sciences, Tokyo, Japan.

Toshiaki Kotani (T)

Department of Orthopedic Surgery, Seirei Sakura Citizen Hospital, Sakura, Japan.

Teppei Suzuki (T)

Department of Orthopedic Surgery, National Hospital Organization, Kobe Medical Center, Kobe, Japan.

Koki Uno (K)

Department of Orthopedic Surgery, National Hospital Organization, Kobe Medical Center, Kobe, Japan.

Hideki Sudo (H)

Department of Advanced Medicine for Spine and Spinal Cord Disorders, Hokkaido University Graduate School of Medicine, Sapporo, Japan.

Satoshi Inami (S)

Department of Orthopedic Surgery, Dokkyo Medical University School of Medicine, Mibu, Japan.

Hiroshi Taneichi (H)

Department of Orthopedic Surgery, Dokkyo Medical University School of Medicine, Mibu, Japan.

Hideki Shigematsu (H)

Department of Orthopedic Surgery, Nara Medical University, Kashihara, Japan.

Kei Watanabe (K)

Department of Orthopedic Surgery, Niigata University Hospital, Niigata, Japan.

Ikuho Yonezawa (I)

Department of Orthopedic Surgery, Juntendo University School of Medicine, Tokyo, Japan.

Ryo Sugawara (R)

Department of Orthopedic Surgery, Jichi Medical University, Shimotsuke, Japan.

Yuki Taniguchi (Y)

Department of Orthopedic Surgery, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.

Shohei Minami (S)

Department of Orthopedic Surgery, Seirei Sakura Citizen Hospital, Sakura, Japan.

Kazuo Kaneko (K)

Department of Orthopedic Surgery, Juntendo University School of Medicine, Tokyo, Japan.

Masaya Nakamura (M)

Department of Orthopedic Surgery, Keio University School of Medicine, Tokyo, Japan.

Morio Matsumoto (M)

Department of Orthopedic Surgery, Keio University School of Medicine, Tokyo, Japan.

Junya Toguchida (J)

Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
Department of Regeneration Science and Engineering, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.
Department of Orthopedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Kota Watanabe (K)

Department of Orthopedic Surgery, Keio University School of Medicine, Tokyo, Japan sikegawa@ims.u-tokyo.ac.jp watakota@gmail.com.

Shiro Ikegawa (S)

Laboratory of Bone and Joint Diseases, RIKEN Center for Integrative Medical Sciences, Tokyo, Japan sikegawa@ims.u-tokyo.ac.jp watakota@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH